Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mirdametinib × Clear all

Phase

Status

Recruiting 7 Completed 6 Terminated 4 Suspended 1 Not yet recruiting 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Cisplatin 124 Carboplatin 124 Drug Therapy 116 Bevacizumab 107 Capecitabine 104 Oxaliplatin 102 Radiotherapy 90 tislelizumab 89 Paclitaxel 89 Cyclophosphamide 88 Gemcitabine 85 pembrolizumab 76 Specimen Handling 72 toripalimab 67 Injections 63 Fluorouracil 63 Magnetic Resonance Spectroscopy 60 sintilimab 59 Surgical Procedures, Operative 56 Docetaxel 55 130-nm albumin-bound paclitaxel 50 Immune Checkpoint Inhibitors 47 anlotinib 46 lenvatinib 44 fludarabine 44 Standard of Care 44 Pemetrexed 43 Biopsy 43 Leucovorin 42 Radiosurgery 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡